Advertisement

Preventing postpartum hemorrhage after cesarean delivery: a network meta-analysis of available pharmacologic agents

Published:September 14, 2021DOI:https://doi.org/10.1016/j.ajog.2021.08.060

      Background

      Postpartum hemorrhage causes a quarter of global maternal deaths. The World Health Organization recommends oxytocin as the first line agent to prevent hemorrhage during cesarean delivery. However, some randomized controlled trials suggest that other uterotonics are superior.

      Objective

      We conducted a network meta-analysis comparing the ability of pharmacologic agents to reduce blood loss and minimize the need for additional uterotonics during cesarean delivery.

      Data Sources

      We searched the Cochrane Central Register of Controlled Trials, Embase, and MEDLINE databases from inception to May 2020.

      Study Eligibility Criteria

      We included randomized controlled trials that compared oxytocin, carbetocin, misoprostol, ergometrine, carboprost, or combinations of these in the prevention of postpartum hemorrhage during cesarean delivery.

      Methods

      We performed a systematic review followed by an NMA in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Quality of the evidence was assessed with the Confidence in Network Meta-Analysis approach and Grading of Recommendations, Assessment, Development and Evaluations tool within the summary of findings table. Our primary outcomes were the estimated blood loss and need for additional uterotonics. Secondary outcomes included nausea and postpartum hemorrhage of >1000 mL. We performed sensitivity analyses to explore the influence of surgical context and oxytocin administration strategy.

      Results

      A total of 46 studies with 7368 participants were included. Of those, 21 trials (6 agents and 3665 participants) formed the “estimated blood loss” network and, considering the treatment effects, certainty in the evidence, and surface under the cumulative ranking curve scores, carbetocin was assessed to probably be superior to oxytocin, but only in reducing the estimated blood loss by a clinically insignificant volume (54.83 mL; 95% confidence interval, 26.48–143.78). Misoprostol, ergometrine, and the combination of oxytocin and ergometrine were assessed to probably be inferior, whereas the combination of oxytocin and misoprostol was assessed to definitely be inferior to oxytocin. A total of 37 trials (8 agents and 6193 participants) formed the “additional uterotonic” network and, again, carbetocin was assessed to probably be superior to oxytocin, requiring additional uterotonics 185 (95% confidence interval, 130–218) fewer times per 1000 cases. Oxytocin plus misoprostol, oxytocin plus ergometrine, and misoprostol were assessed to probably be inferior, whereas carboprost, ergometrine, and the placebo were definitely inferior to oxytocin. For both primary outcomes, oxytocin administration strategies had a higher probability of being the best uterotonic, if initiated as a bolus.

      Conclusion

      Carbetocin is probably the most effective agent in reducing blood loss and the need for additional uterotonics. Oxytocin appears to be more effective when initiated as a bolus.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Say L.
        • Chou D.
        • Gemmill A.
        • et al.
        Global causes of maternal death: a WHO systematic analysis.
        Lancet Glob Health. 2014; 2: e323-e333
        • Al-Zirqi I.
        • Vangen S.
        • Forsén L.
        • Stray-Pedersen B.
        Effects of onset of labor and mode of delivery on severe postpartum hemorrhage.
        Am J Obstet Gynecol. 2009; 201: 273.e1-273.e9
        • Martin J.A.
        • Hamilton B.E.
        • Osterman M.J.K.
        • Driscoll A.K.
        Births: final data for 2018.
        Natl Vital Stat Rep. 2019; 68: 1-47
        • World Health Organization
        WHO recommendations. 2018.
        (Available at:)
        https://www.ncbi.nlm.nih.gov/books/NBK535987/
        Date accessed: August 13, 2020
        • Gallos I.D.
        • Papadopoulou A.
        • Man R.
        • et al.
        Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis.
        Cochrane Database Syst Rev. 2018; 12: CD011689
        • Phaneuf S.
        • Linares B.R.
        • TambyRaja R.L.
        • MacKenzie I.Z.
        • Bernal A.L.
        Loss of myometrial oxytocin receptors during oxytocin-induced and oxytocin-augmented labour.
        Reproduction. 2000; 120: 91-97
        • Robinson C.
        • Schumann R.
        • Zhang P.
        • Young R.C.
        Oxytocin-induced desensitization of the oxytocin receptor.
        Am J Obstet Gynecol. 2003; 188: 497-502
        • Physiological Reviews
        The oxytocin receptor system: structure, function, and regulation. 2001.
        (Available at:)
        • Heesen M.
        • Carvalho B.
        • Carvalho J.C.A.
        • et al.
        International consensus statement on the use of uterotonic agents during caesarean section.
        Anaesthesia. 2019; 74: 1305-1319
        • Moher D.
        • Liberati A.
        • Tetzlaff J.
        • Altman D.G.
        • PRISMA Group
        Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
        BMJ. 2009; 339: b2535
        • Sterne J.A.C.
        • Savović J.
        • Page M.J.
        • et al.
        RoB 2: a revised tool for assessing risk of bias in randomised trials.
        BMJ. 2019; 366: l4898
        • Salanti G.
        • Ades A.E.
        • Ioannidis J.P.A.
        Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial.
        J Clin Epidemiol. 2011; 64: 163-171
        • Neupane B.
        • Richer D.
        • Bonner A.J.
        • Kibret T.
        • Beyene J.
        Network meta-analysis using R: a review of currently available automated packages.
        PLoS One. 2014; 9e115065
        • Zein El Abdeen E.
        • Shehata N.
        Carbetocin versus oxytocin and ergometrine for prevention of postpartum hemorrhage following caesarean section.
        Evid Based Womens Health. 2018; 0: 138-143
        • Abdelaleem A.A.
        • Abdelaleem N.A.
        • Abbas A.M.
        Intrauterine misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss: a randomised clinical trial.
        Int J Reprod Contracept Obstet Gynecol. 2019; 8: 1662-1667
        • Abdelhamid A.N.
        • Sayyed T.M.
        • Hamza H.A.
        • Emara A.A.
        Comparison of the effect of carbetocin versus oxytocin during cesarean section in women with high risk of postpartum hemorrhage.
        Menoufia Med J. 2019; 32: 1333-1337
        • Acharya G.
        • Al-Sammarai M.T.
        • Patel N.
        • Al-Habib A.
        • Kiserud T.
        A randomized, controlled trial comparing effect of oral misoprostol and intravenous syntocinon on intra-operative blood loss during cesarean section.
        Acta Obstet Gynecol Scand. 2001; 80: 245-250
        • Adefuye P.O.
        • Akindele R.A.
        • Adefuye B.O.
        • Durojaiye B.O.
        • Adeiyi T.O.
        Effect of pre-operative sub-lingual misoprostol versus intravenous oxytocin on caesarean operation blood loss.
        East Afr Med J. 2012; 89: 294-300
        • Ali R.
        • Hina F.
        Postpartum hemorrhage; comparison of efficacy of ergometrine with misoprostol in prophylaxis in cesarean section.
        Prof Med J. 2012; 19: 360-364
        • Alwani M.
        • Singh S.
        • Thakur R.
        • Mishra S.
        A randomized study comparing rectally administered misoprostol after spinal anesthesia versus intramuscular oxytocin for prevention of postpartum hemorrhage in caesarean section.
        Int J Reprod Contracept Obstet Gynecol. 2014; 3: 512-515
        • Anvaripour A.
        • Shahryari H.
        • Ahmadi S.
        • Ghasemi S.
        • Mirzaei K.
        Comparison the effects of oxytocin and methylergonovine in elective caesarean section under spinal anesthesia.
        Arch Gynecol Obstet. 2013; 287: 979-983
        • Attilakos G.
        • Psaroudakis D.
        • Ash J.
        • et al.
        Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial.
        BJOG. 2010; 117: 929-936
        • Barton S.R.
        • Jackson A.
        The safety and efficacy of carbetocin to control uterine bleeding following caesarean section.
        Prenat Neonatal Med. 1996; 1: 185
        • Begum T.
        • Yeasmin S.
        • Chakma S.
        Sublingual misoprostol versus oxitocin infusion to reduce blood loss in caesarean section.
        BJOG. 2015; 122: 258
        • Borruto F.
        • Treisser A.
        • Comparetto C.
        Utilization of carbetocin for prevention of postpartum hemorrhage after cesarean section: a randomized clinical trial.
        Arch Gynecol Obstet. 2009; 280: 707-712
        • Boucher M.
        • Horbay G.L.
        • Griffin P.
        • et al.
        Double-blind, randomized comparison of the effect of carbetocin and oxytocin on intraoperative blood loss and uterine tone of patients undergoing cesarean section.
        J Perinatol. 1998; 18: 202-207
        • Chaudhuri P.
        • Banerjee G.B.
        • Mandal A.
        Rectally administered misoprostol versus intravenous oxytocin infusion during cesarean delivery to reduce intraoperative and postoperative blood loss.
        Int J Gynaecol Obstet. 2010; 109: 25-29
        • Chou M.M.
        • MacKenzie I.Z.
        A prospective, double-blind, randomized comparison of prophylactic intramyometrial 15-methyl prostaglandin F2α, 125 micrograms, and intravenous oxytocin, 20 units, for the control of blood loss at elective cesarean section.
        Am J Obstet Gynecol. 1994; 171: 1356-1360
        • Dansereau J.
        • Joshi A.K.
        • Helewa M.E.
        • et al.
        Double-blind comparison of carbetocin versus oxytocin in prevention of uterine atony after cesarean section.
        Am J Obstet Gynecol. 1999; 180: 670-676
        • Eftekhari N.
        • Doroodian M.
        • Lashkarizadeh R.
        The effect of sublingual misoprostol versus intravenous oxytocin in reducing bleeding after caesarean section.
        J Obstet Gynaecol. 2009; 29: 633-636
        • El Behery M.M.
        • El Sayed G.A.
        • El Hameed A.A.
        • Soliman B.S.
        • Abdelsalam W.A.
        • Bahaa A.
        Carbetocin versus oxytocin for prevention of postpartum hemorrhage in obese nulliparous women undergoing emergency cesarean delivery.
        J Matern Fetal Neonatal Med. 2016; 29: 1257-1260
        • Elbohoty A.E.
        • Mohammed W.E.
        • Sweed M.
        • Bahaa Eldin A.M.B.
        • Nabhan A.
        • Abd-El-Maeboud K.H.
        Randomized controlled trial comparing carbetocin, misoprostol, and oxytocin for the prevention of postpartum hemorrhage following an elective cesarean delivery.
        Int J Gynaecol Obstet. 2016; 134: 324-328
        • Fahmy A.A.
        • Fawzy M.
        Oxytocin infusion after oxytocin bolus and carbetocin bolus to reduce blood loss during and after cesarean section—a randomized clinical trial.
        Med J Cairo Univ. 2015; 83: 79-83
        • Fahmy N.G.
        • Yousef H.M.
        • Zaki H.V.
        Comparative study between effect of carbetocin and oxytocin on isoflurane-induced uterine hypotonia in twin pregnancy patients undergoing cesarean section.
        Egypt J Anaesth. 2016; 32: 117-121
        • Fazel M.R.
        • Mansoure-Samimi
        • Esmaeil-Fakharian
        A comparison of rectal misoprostol and intravenous oxytocin on hemorrhage and homeostatic changes during cesarean section.
        Middle East J Anaesthesiol. 2013; 22: 41-46
        • Gavilanes P.
        • Morales M.F.
        • Velasco S.
        • Teran E.
        Sublingual misoprostol is as effective as intravenous oxytocin to reduce intra-operative blood loss during cesarean delivery in women living at high altitude.
        J Matern Fetal Neonatal Med. 2016; 29: 559-561
        • Jenkumwong P.
        • Ratchanon S.
        • Ouitrakul S.
        Double-blind randomized comparison of carbetocin versus oxytocin for decrease blood loss from cesarean section in low-risk uterine atony.
        J Preg Child Health. 2017; 4: 1-4
        • Kikutani T.
        • Kikutani M.
        • Oshima M.
        • Sugimoto K.
        • Shimada Y.
        [Effects of Methylergometrine and oxytocin on blood loss and uterine contraction during cesarean section].
        Masui. 2006; 55: 590-594
        • Lamont R.F.
        • Morgan D.J.
        • Logue M.
        • Gordon H.
        A prospective randomised trial to compare the efficacy and safety of hemabate and syntometrine for the prevention of primary postpartum haemorrhage.
        Prostaglandins Other Lipid Mediat. 2001; 66: 203-210
        • Lokugamage A.U.
        • Paine M.
        • Bassaw-Balroop K.
        • Sullivan K.R.
        • Refaey H.E.
        • Rodeck C.H.
        Active management of the third stage at caesarean section: a randomised controlled trial of misoprostol versus syntocinon.
        Aust N Z J Obstet Gynaecol. 2001; 41: 411-414
        • Mohamed Maged A.
        • Ragab A.S.
        • Elnassery N.
        • Ai Mostafa W.
        • Dahab S.
        • Kotb A.
        Carbetocin versus syntometrine for prevention of postpartum hemorrhage after cesarean section.
        J Matern Fetal Neonatal Med. 2017; 30: 962-966
        • Mannaerts D.
        • Van der Veeken L.
        • Coppejans H.
        • Jacquemyn Y.
        Adverse effects of carbetocin versus oxytocin in the prevention of postpartum haemorrhage after caesarean Section: a randomized controlled trial.
        J Preg. 2018; 2018: 1374150
        • Moertl M.G.
        • Friedrich S.
        • Kraschl J.
        • Wadsack C.
        • Lang U.
        • Schlembach D.
        Haemodynamic effects of carbetocin and oxytocin given as intravenous bolus on women undergoing caesarean delivery: a randomised trial.
        BJOG. 2011; 118: 1349-1356
        • Mohamed H.F.
        • Mustafa G.F.
        • Ibrahim M.A.
        • Stefanos G.E.
        Comparative study between intravenous bolus dose of carbetocin versus oxytocin during cesarean delivery in healthy parturients on blood loss: a randomized control trial.
        Med J Cairu Univ. 2015; 83: 167-172
        • Ortiz-Gómez J.R.
        • Morillas-Ramírez F.
        • Fornet-Ruiz I.
        • Palacio-Abizanda F.J.
        • Bermejo-Albares L.
        Clinical and pharmacological study of the efficacy of carbetocin in elective caesareans compared to low and usual doses of oxytocin.
        Rev Esp Anestesiol Reanim. 2013; 60: 7-15
        • Othman E.R.
        • Fayez M.F.
        • El Aal D.E.
        • El-Dine Mohamed H.S.
        • Abbas A.M.
        • Ali M.K.
        Sublingual misoprostol versus intravenous oxytocin in reducing bleeding during and after cesarean delivery: a randomized clinical trial.
        Taiwan J Obstet Gynecol. 2016; 55: 791-795
        • Owonikoko K.M.
        • Arowojolu A.O.
        • Okunlola M.A.
        Effect of sublingual misoprostol versus intravenous oxytocin on reducing blood loss at cesarean section in Nigeria: a randomized controlled trial.
        J Obstet Gynaecol Res. 2011; 37: 715-721
        • Pakniat H.
        • Khezri M.B.
        The effect of combined oxytocin–misoprostol versus oxytocin and misoprostol alone in reducing blood loss at Cesarean delivery: a prospective randomized double-blind study.
        J Obstet Gynaecol India. 2015; 65: 376-381
        • Rabow S.
        • Jonsson E.
        • Jonsson H.
        • Olofsson P.
        Cardiovascular effects of oxytocin and carbetocin at caesarean section, a prospective double-blind randomised study using non-invasive pulse wave analysis.
        Acta Anaesthesiol Scand. 2017; 61: 1053
        • Razali N.
        • Md Latar I.L.M.
        • Chan Y.K.
        • Omar S.Z.
        • Tan P.C.
        Carbetocin compared to oxytocin in emergency cesarean section: a randomized trial.
        Eur J Obstet Gynecol Reprod Biol. 2016; 198: 35-39
        • Rosseland L.A.
        • Hauge T.H.
        • Grindheim G.
        • Stubhaug A.
        • Langesæter E.
        Changes in blood pressure and cardiac output during cesarean delivery: the effects of oxytocin and carbetocin compared with placebo.
        Anesthesiology. 2013; 119: 541-551
        • Elgafor el Sharkwy I.A.
        Carbetocin versus sublingual misoprostol plus oxytocin infusion for prevention of postpartum hemorrhage at cesarean section in patients with risk factors: a randomized, open trail study.
        Arch Gynecol Obstet. 2013; 288: 1231-1236
        • Farhad Siddiqua S.
        • Abbasi S.
        • Haque N.
        • Saqif Hasan A.
        Carbetocin versus oxytocin in the active management of third stage of labour following caesarean section: an open label randomised control trial [IO052].
        BJOG. 2017; 124: 28
        • Taheripanah R.
        • Shoman A.
        • Karimzadeh M.A.
        • Zamaniyan M.
        • Malih N.
        Efficacy of oxytocin versus carbetocin in prevention of postpartum hemorrhage after cesarean section under general anesthesia: a prospective randomized clinical trial.
        J Matern Fetal Neonatal Med. 2018; 31: 2807-2812
        • Uy D.-L.
        • Pangilian N.C.P.
        • Ricero-Cabingue C.
        Carbetocin versus oxytocin for the prevention of postpartum hemorrhage following elective cesarean section: Rizal Medical Center experience.
        Philipp J Obstet Gynecol. 2013; 37: 71-79
        • Vimala N.
        • Mittal S.
        • Kumar S.
        Sublingual misoprostol versus oxytocin infusion to reduce blood loss at cesarean section.
        Int J Gynaecol Obstet. 2006; 92: 106-110
        • Whigham C.A.
        • Gorelik A.
        • Loughnan T.E.
        • Trivedi A.
        Carbetocin versus oxytocin to reduce additional uterotonic use at non-elective caesarean section: a double-blind, randomised trial (.).
        J Matern Fetal Neonatal Med. 2016; 29: 3866-3869
        • Yaliwal R.G.
        • Bidri S.R.
        • Navani A.S.
        A randomized controlled trial of sublingual misoprostol—600μg versus intravenous oxytocin—10IU in prevention of post partum hemorrhage during cesarean section.
        Int J Reprod Contracept Obstet Gynecol. 2019; 8: 3865-3869
        • Yamaguchi E.T.
        • Cardoso M.M.
        • Torres M.L.
        • et al.
        Serum oxytocin concentrations in elective caesarean delivery: a randomized comparison of three infusion regimens.
        Int J Obstet Anesth. 2011; 20: 224-228
        • Nikolakopoulou A.
        • Higgins J.P.T.
        • Papakonstantinou T.
        • et al.
        CINeMA: an approach for assessing confidence in the results of a network meta-analysis.
        PLOS Med. 2020; 17e1003082
        • Altman D.G.
        • Royston P.
        The cost of dichotomising continuous variables.
        BMJ. 2006; 332: 1080
        • Al Kadri H.M.F.
        • Al Anazi B.K.
        • Tamim H.M.
        Visual estimation versus gravimetric measurement of postpartum blood loss: a prospective cohort study.
        Arch Gynecol Obstet. 2011; 283: 1207-1213
        • Doctorvaladan S.V.
        • Jelks A.T.
        • Hsieh E.W.
        • Thurer R.L.
        • Zakowski M.I.
        • Lagrew D.C.
        Accuracy of blood loss measurement during cesarean delivery.
        AJP Rep. 2017; 7: e93-e100
        • Carvalho J.C.A.
        • Balki M.
        • Kingdom J.
        • Windrim R.
        Oxytocin requirements at elective cesarean delivery: a dose-finding study.
        Obstet Gynecol. 2004; 104: 1005-1010
        • Balki M.
        • Ronayne M.
        • Davies S.
        • et al.
        Minimum oxytocin dose requirement after cesarean delivery for labor arrest.
        Obstet Gynecol. 2006; 107: 45-50
        • Khan M.
        • Balki M.
        • Ahmed I.
        • Farine D.
        • Seaward G.
        • Carvalho J.C.A.
        Carbetocin at elective cesarean delivery: a sequential allocation trial to determine the minimum effective dose.
        Can J Anesth. 2014; 61: 242-248
        • Nguyen-Lu N.
        • Carvalho J.C.A.
        • Farine D.
        • Seaward G.
        • Ye X.Y.
        • Balki M.
        Carbetocin at cesarean delivery for labour arrest: a sequential allocation trial to determine the effective dose.
        Can J Anesth. 2015; 62: 866-874
        • Parry Smith WRP
        • Papadopoulou A.
        • Thomas E.
        • et al.
        Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis.
        Cochrane Database Syst Rev. 2020; 11: CD012754
        • Kovacheva V.P.
        • Soens M.A.
        • Tsen L.C.
        A randomized, double-blinded trial of a “rule of threes” algorithm versus continuous infusion of oxytocin during elective cesarean delivery.
        Anesthesiology. 2015; 123: 92-100

      Linked Article